Current pain and headache reports
-
The numbers of older people, particularly those older than 85 years of age, are increasing rapidly. Aging and chronic conditions contribute to the limitation in response to stress or insults in the elderly and impact assessment and management of pain. ⋯ Physiological alteration in body composition and renal and hepatic function alter distribution and elimination of medications and metabolites. Non-medical treatments also may be effective in managing pain and should be considered for older patients.
-
A number of primary headache syndromes are marked by their short duration of pain. Many of these syndromes have their own unique treatment, so they must be recognized by practicing physicians. In this article, a number of the short-lasting headache disorders are reviewed, including chronic paroxysmal hemicrania, SUNCT syndrome, hypnic headache, exploding head syndrome, primary stabbing headache, and cough headache.
-
Colloid cysts of the third ventricle are rare intracranial tumors, accounting for 0.5% of intracranial tumors. Colloid cysts represent 2% of gliomas, are more common in men than women, and usually are diagnosed between the third and fifth decades of life. The primary presenting complaint of this disorder is headache. ⋯ Colloid cysts of the third ventricle are diagnosed by computed tomography or magnetic resonance imaging and treatment is surgical. This rare type of headache disorder is significant because it is associated with sudden death. Recognition of the unusual features of colloid cyst headache may result in decreased mortality in this disorder.
-
Opioid therapy for pain is the subject of numerous randomized clinical trials. Opioids are being developed for delivery by a wide variety of mechanisms. New opioids are becoming available for clinical use. This review surveys recent developments in these clinical trials and provides an overview of what may be expected in the near future for opioid management of pain.
-
Migraine is a common, disabling disorder that often requires preventive treatment. The decision to treat migraine preventively generally is based on disability, problems with acute medicines, patient preference, risk of acute medication overuse, special circumstances, and concern that high migraine attack frequency may be a risk factor for chronic daily headache. Migraine and epilepsy are comorbid episodic central nervous system disorders that can have stereotyped symptoms with negative and positive phenomena. ⋯ Valproic acid, topiramate and, to a lesser extent, gabapentin, have demonstrated efficacy in randomized, placebo-controlled trials. Lamotrigine may be effective at controlling migraine aura, but has not demonstrated effectiveness at controlling migraine headache. Anticonvulsants are a useful option for the preventive treatment of migraine.